Introduction {#s0005}
============

Fungal infections are responsible of the death of an estimated 1.5 million people per year worldwide. Yeasts of the *Candida* genus are the second most numerous agents of fungal infections, with a prominent contribution by *Candida albicans*, which causes over 400,000 cases of life-threatening systemic infections and 200,000 deaths per year ([@b0040]). Only four classes of antifungal drugs are available for patient treatment and the emergence of resistance is becoming a serious concern. The fungistatic group of azoles and the more recently-developed fungicidal group of echinocandins constitute the two major classes of antifungals used to treat patients. Azoles block the biosynthesis of ergosterol -- an essential sterol for fungal cell membranes -- by targeting the cytochrome P450 14-α demethylase enzyme, Erg11, which catalyzes the conversion of lanosterol to ergosterol, thereby affecting membrane integrity and inhibiting fungal growth ([@b0170], [@b0305]). On the other hand, echinocandins, a class of compounds developed between 2001 and 2006, target the catalytic subunit of the β-1,3 glucan synthase protein complex ([@b0245]). Studies of the molecular mechanisms of resistance to these two classes of antifungal compounds (recently reviewed in ([@b0285])) have revealed that there are three major mechanisms leading to resistance in *C. albicans*: overexpression of multidrug efflux pump-encoding genes, notably *CDR1*, *CDR2* and *MDR1* ([@b0270], [@b0275]), amino acid substitutions in the target proteins (ex: Erg11, Fks1) and alteration in the levels of proteins involved in sensitivity to the drug (ex: Erg3, Erg11). In addition, the formation of fungal biofilms can also be considered as a form of antifungal resistance mechanism due to the ability of the biofilm extracellular matrix (ECM) to bind and entrap antifungal compounds, particularly azoles and amphotericin B ([@b0080], [@b0300], [@b0310], [@b0350]).

In this context, alternative antifungal targets and/or ways to improve the fungicidal effect of existing antifungals are being sought. Such approaches notably involve targeting chaperones such as Hsp90 or components of stress signaling pathways, since these targets are more likely to simultaneously affect resistance to different classes of antifungals, morphogenesis mechanisms, cellular fitness and adaptation to changing environments. Key studies have been conducted in these areas by, for example, Brown and colleagues ([@b0035]) and Cowen and coworkers (Singh et al., 2009). Works by this latter group established the complex connections between Pkc1, Hsp90 and calcineurin suggesting interesting new strategies to treat fungal infections ([@b0175]). However, these cellular targets suffer from a major drawback in that they are conserved in mammalian host cells, which makes achieving fungal specificity a real challenge. Factors that regulate the pathogen's cell wall therefore remain a strong target for new, fungus-specific, therapeutic approaches.

Here we describe the role of Smi1, a *C. albicans* protein homologous to the *Saccharomyces cerevisiae* hub protein, Knr4, which interacts physically with both the Slt2 MAP kinase and calcineurin, thus connecting the two primary signaling pathways involved in cell wall maintenance during stress: the cell wall integrity pathway (CWI) and the calcineurin pathway ([@b0055], [@b0215]). Although its precise molecular mode of action is currently unknown, it has been shown that two conserved serine residues, S~200~ and S~203,~ phosphorylated *in vivo*, are essential for Krn4 function in signal transmission ([@b0100], [@b0010]). Knr4 is required for resistance to cell wall stress induced by elevated temperature or by the presence of antifungal compounds, including caspofungin ([@b0180], [@b0195]). Knr4 also plays a role in filamentous and pseudohyphal growth, mucin secretion and agar invasion ([@b0020]). Similarly, GS1 protein, the homolog of Knr4 and Smi1 in the model filamentous fungus, *Neurospora crassa,* is also involved in the control of morphogenesis, caspofungin sensitivity and the synthesis of cell wall constituents, notably β-glucans ([@b0090], [@b0265], [@b0290]).

The *C. albicans* genome encodes two homologs of *KNR4: SMI1 and SMI1B*. Previous studies have shown that deletion of *SMI1* affects cell wall β-glucan synthesis, biofilm formation and biofilm extracellular matrix production, as well as biofilm-associated resistance to fluconazole ([@b0235]). Global transcriptomic studies indicate that *SMI1* expression is induced in hyphal and planktonic cells by the Cyr1 adenylate cyclase, a positive regulator of *C. albicans* hyphal morphogenesis, and is also biofilm-induced, while it is repressed by the Hap43 regulatory protein and caspofungin ([@b0190]). Much less is known about *SMI1B*, although it appears to be the closest homolog of *S. cerevisiae KNR4* according to phylogeny.

In this work we further characterize the function of *SMI1* in *C. albicans*. We provide evidence that Smi1 is a functional homolog of *S. cerevisiae* Knr4, that its correct expression is critical for the regulation of fungal cell wall integrity and biophysical properties, and that the cellular localization of Smi1-GFP in yeast and hyphal cells is consistent with those observed for its counterparts, *i.e.* Knr4 in *S. cerevisiae* yeasts and GS1 in the hyphae of *N. crassa.*

Material and methods {#s0010}
====================

Strains and growth media {#s0015}
------------------------

The *C. albicans* and *S. cerevisae* strains used in this study are listed in [Table 1](#t0005){ref-type="table"}. Depending on experimental conditions, yeast strains were grown in YPD (1% (W/V) yeast extract, 2% peptone, and 1% dextrose), YP (1% (W/V) yeast extract, 2% peptone) supplemented with 10% Fetal Bovine Serum (FBS), or SD (synthetic dextrose, 0.67% (W/V) yeast nitrogen base (YNB; Difco) with 2% glucose) supplemented as necessary with arginine, histidine or uridine (20 mg/l). Agar (2%) was used for growth on solid medium. *Escherichia coli* strains TOP10 (Invitrogen) or DH5α were used for DNA cloning and maintenance of the plasmid constructs.Table 1Yeast strains used in this study.Strain nameGenotypeReference or Source*Candida albicans* strains:**BWP17***ura3*Δ*::λimm434/ura3*Δ*::λimm434, arg4*Δ*::hisG/arg4*Δ*::hisG, his1*Δ*::hisG/his1*Δ*::hisG*[@b0340]**CEC161**Isogenic to BWP17 but *arg4*Δ*::hisG/ARG4, his1*Δ*::hisG/HIS1*[@b0105]**BWP17 AHU**\
**(= CEC 369)**Isogenic to CEC161 but *ura3::limm434/URA3*[@b0225]***smi1*** Δ/ΔIsogenic to BWP17 but *smi1*Δ*::HIS1*/*smi1*Δ*::ARG4, RPS1/rps1::*CIp10This study***smi1*** Δ/Δ+**P~TDH3~*SMI1***Isogenic to *smi1*Δ/Δ but *RPS1/rps1::*CIp10*-P~TDH3~-SMI1*This study***SMI1*-OE**Isogenic to CEC161 but *RPS1/rps1::*CIp10*-P~TDH3~-SMI1*This study**DAY185***ura3::imm434/ura3::imm434 his1::hisG::HIS1/his1::hisG arg4::hisG::ARG4-URA3/arg4::hisG*[@b0070]***SMI1*-GFP**DAY185 *SMI1*::*SMI1-GFP-NAT*This study  *Saccharomyces cerevisiae* strains:**BY4741a**MAT **a**; *his3*Δ*1 leu2*Δ*0; met15*Δ*0; ura3*Δ*0*[@b0025]***knr4Δ***BY4741**a***YGR229c::KanMX4*YKO Collection (Open Biosystems)**W303-2N**MAT **a**/α *ura3-1/ura3-1 leu2-3,112/leu2-3,112 trp1-1/trp1-1 his3-11,15/his3-11,15 ade2-1/ade2-1 can1-100/can1-100*Rodney Rothstein.**HM1315**W303-2N *YGR229c::KanMX4/YGR229c::KanMX4*This study.

Plasmid construction and generation of epitope-tagged or mutant strains {#s0020}
-----------------------------------------------------------------------

*C. albicans SMI1* gene was PCR amplified with primers: Sense SMI1 New start and Antisense SMI1 (sequences in [Supplementary material Table S1](#s0100){ref-type="sec"}). The PCR product was then cloned in the *S. cerevisiae* expression vector YEplac195 *PGK/CYC1* between the *S. cerevisiae PGK1* promotor P~PGK1~ and the *S. cerevisiae CYC1* terminator sequences (personal gift of Dr. J.L. Parrou, based on YEplac195 ([@b0130])), thus yielding the p*SMI1* plasmid. Plasmid p*KNR4* expressing the *S. cerevisae KNR4* gene with its own promotor and terminator on a multicopy vector has been described previously ([@b0200]).

*S. cerevisiae* cells were transformed using the lithium acetate method ([@b0135]). *C. albicans* cells were transformed using the lithium acetate protocol of ([@b0330]), followed by selection of transformants for uridine, arginine or histidine prototrophy when using the *URA3, ARG4* or *HIS1* markers, respectively.

Construction of *C. albicans* original *smi1* Δ/Δ and *smi1B* Δ/Δ knock-out mutants used PCR-generated *ARG4* and *HIS1* disruption cassettes flanked by 120 base pairs of target homology region (primer sequences are provided in [Supplementary material Table S1](#s0100){ref-type="sec"}) as described by ([@b0145]) and ([@b0280]). Independent transformants were produced and the gene replacements were verified by PCR on whole yeast cells as described previously ([@b0145], [@b0280]).

The *SMI1* (C1_07870C_A) gene was amplified using primers: SMI1 Forward and SMI1 Reverse (sequences provided in [Supplementary material Table S1](#s0100){ref-type="sec"}). The resulting 1.8 kb PCR product was purified and inserted into the GTW sequences of pEntry (Gateway™ system, Invitrogen). Recombination of pEntry-SMI1 plasmid and CIp10-P*~TDH3~*-GTW plasmid ([@b0045]) was performed also using the Gateway™ (system Invitrogen). CIp10-P*~TDH3~*-GTW vector is a derivative of plasmid CIp10 ([@b0230]) that carries the sequence for integration at the *RPS1* locus on *C. albicans* Chr1, the *URA3* gene, and a Gateway™ cassette flanked by the attR sequences and preceded by the *C. albicans* P*~TDH3~* constitutive promoter ([@b0075]). The resulting CIp10-P*~TDH3~*-*SMI1* construct was then used to transform by genome integration through targeted homologous recombination at the genomic *RPS10* locus the host strain BWP17, yielding *SMI1*-OE strain, as well as the *smi1* Δ/Δ original mutant, yielding *smi1* Δ/Δ+P~TDH3~ *SMI1*. To allow phenotype comparisons with the *SMI1-*OE strain, we used as control strain BWP17 AHU ([@b0225]) and the *smi1* Δ/Δ original mutant was also transformed by the empty Clp10 vector, ensuring that all of these strains carry a functional *URA3* allele (see [Table 1](#t0005){ref-type="table"} for full genotypes of the yeast strains used in this study).

GFP tagging of Smi1 {#s0025}
-------------------

Smi1 was C-terminally-tagged with GFP by amplifying GFP-NAT cassette from the pGFP-NAT1 plasmid ([@b0220]) using primers gSmi1 \_F^a^ and gSmi1_R^a^ containing 100 bp of flanking homology to the *SMI1* terminator and the C-terminus of the *SMI1* ORF (C1_07870C_A), respectively (primer sequences are provided in [Supplementary material Table S1](#s0100){ref-type="sec"}). Transformants were selected on YPD agar containing 300 µg/ml nourseothricin (Sigma). Integration of the GFP-NAT cassette was confirmed by PCR using primers sSmi1_F and sFP_R, which anneal to the chromosome outside the targeted region and within the cassette, respectively (primer sequences in [Supplementary material Table S1](#s0100){ref-type="sec"}).

Microscopy of Smi1-GFP {#s0030}
----------------------

Yeast were grown for 2 h at 30 °C in YNB medium containing amino acids and (NH~4~)~2~SO~4~ (Sigma Aldrich). Morphogenesis was induced at 37 °C for 3 h in 20% foetal calf serum (FCS), 2% glucose. Cells were imaged on µ-slides (Ibidi, Martinsried, Germany). Images of Smi1-GFP localization were captured on an UltraVIEW® VoX spinning disk confocal microscope (Nikon, Surrey, UK), using a 488 nm laser. Multiple Z-stack images were acquired and Z-stack projections at maximum intensity were created using Volocity 6.3 software (Perkin Elmer).

Phenotypic sensitivity tests {#s0035}
----------------------------

Drop tests to evaluate the sensitivity of different strains and mutants to cell wall affecting drugs were performed as previously described ([@b0260]) with minor modifications ([@b0200]). Briefly, yeast cells were grown in liquid YPD to OD~600~ of 1 ± 0.1, then concentrated by centrifugation and resuspended in sterile water to an OD~600~ of 8. Serial dilutions of 1/1, 1/10, 1/100 and 1/1000 were then spotted on solid media containing either calcofluor white or Caspofungin at the indicated concentrations. Growth was scored and photographs taken after 48 h of incubation at 30 °C, or at 37 °C for testing the sensitivity to elevated temperature.

Atomic Force Microscopy (AFM) {#s0040}
-----------------------------

*Sample preparation for AFM experiments*: Yeast cells were concentrated by centrifugation, washed two times in acetate buffer (18 mM CH~3~COONa, 1 mM CaCl~2~, 1 mM MnCl~2~, pH 5.2), resuspended in the same buffer, and immobilized on polydimethylsiloxane (PDMS) stamps prepared as described by ([@b0065], [@b0120]). Briefly, freshly oxygen-activated microstructured PDMS stamps were covered with a total of 100 μl of cell suspension and allowed to stand for 15 min at room temperature. Yeast cells were then deposited into the stamps microstructures by convective (capillary) assembly.

*AFM procedures:* For imaging and force spectroscopy, we used an AFM Nanowizard III (JPK Instruments, Berlin, Germany). Force curves were then recorded in acetate buffer in quantitative-imaging mode (JPK Instruments, 2011, QITM mode-quantitative imaging with Nano-Wizard 3 AFM) ([@b0050], [@b0125], [@b0295]) with MLCT AUWH cantilevers (nominal spring constants: 0.01, 0.1, and 0.5 N/m). For imaging, cantilevers with a spring constant of 0.01 N/m were used. For force spectroscopy experiments, cantilevers with spring constants of 0.1 and 0.5 N/m were used. The maximal applied force was kept at 1 nN, the force curves lengh (Z-range) at 2 μm and the approach/retract speed at either 20 or 2 μm s^−1^ for both imaging and force spectroscopy. The spring constant of each cantilever was determined by the thermal-noise method ([@b0165]). For elasticity measurements, force maps of 32 by 32 or 64 by 64, hence either 1024 or 4096 force curves were recorded on an area of 1--4 μm^2^ on top of the cells, always avoiding any bud or budscar. The force-distance curves recorded were transformed into force-indentation curves by subtracting the cantilever deflection on a solid surface. The indentation curves were then fitted to the Hertz model ([@b0155]).

Results {#s0045}
=======

Conservation of cellular function between *S. cerevisiae Knr4* and *C. albicans Smi1* {#s0050}
-------------------------------------------------------------------------------------

The genome of the human fungal pathogen *C. albicans* contains two distinct homologs of the *S. cerevisiae KNR4* gene, *SMI1* (C1_07870C_A) and *SMI1B* (C3_05350C_A)*.* Gene deletion mutants for each gene were generated and initial phenotypic analysis showed a strong phenotype (sensitivity to Calcofluor White (CFW) or SDS) for the *smi1* Δ/Δ mutant but only a milder one for the *smi1B* Δ/Δ mutant ([Supplementary material, Fig. S1](#s0100){ref-type="sec"}). We therefore focused on the role of Smi1 in this study.

The *SMI1* open reading frame was amplified and cloned into a *S. cerevisiae* expression vector, under the control of the strong and constitutive *ADH1* promoter. The *SMI1* coding sequence is 1863 bp and contains two CTG codons at positions 1717 and 1762, which have a 97% chance of translation as a Serine in *C. albicans* through non-canonical codon usage in this fungus, compared to a Leucine in *S. cerevisiae* ([@b0335]). These two codons are located within the C-terminus of Smi1, which is less conserved than the central domain among members of the fungal Knr4/Smi1 super-family of proteins (See [Supplementary material, Fig. S2](#s0100){ref-type="sec"}). The C-terminus of Knr4 is largely unstructured and not directly necessary for protein function in *S. cerevisiae* ([@b0055], [@b0215]). Hence, we tested the ability of the *C. albicans SMI1* gene, retaining its two ambiguous codons, to complement the cell wall-related phenotypes of *S. cerevisiae knr4* null mutants. Our phenotypic screen included sensitivity to CFW, SDS, caspofungin and elevated temperature in haploid and diploid *S. cerevisiae* genetic backgrounds. CFW is a compound that binds to nascent chitin fibrils and has been used to identify fungal cell wall mutants (Ram et al., 1994). Expression of *SMI1* in *S. cerevisiae* was able to complement these phenotypes ([Fig. 1](#f0005){ref-type="fig"}A and data not shown), including the growth defect at elevated temperature ([Fig. 1](#f0005){ref-type="fig"}B), a specific defect in this organism that is linked to cell cycle progression through START ([@b0110], [@b0210]). The function of the Smi1/Knr4 proteins thus appears to be conserved between the two species despite their phylogenetic distance and the differences between the two protein sequences, which share only 34% identity and 49% similarity (Fig. S2).Fig. 1*C. albicans SMI1* gene expression suppresses the cell wall associated phenotypes of *S. cerevisiae knr4* Δ mutants. A) Transformed haploid control strain BY4741a and mutant strain *knr4*Δ with either empty plasmid YEplac195 *PGK/CYC1*, p*SMI1* (Yeplac195 bearing *C. albicans SMI1* gene under P~PGK1~) or p*KNR4* bearing *S. cerevisiae KNR4* gene, were grown in liquid SD medium lacking uracil at 30 °C to an OD~600~ of 1, and concentrated to OD600 8 ± 0. Serial dilutions of yeast cultures were spotted on YPD plates in the absence or presence of 150 ng caspofungin ml^−1^. Growth was scored after 2 days at 30 °C. B) Transformed diploid control strain W3032N and mutant strain HM1315 *knr4* Δ/Δ with either empty YEplac195 *PGK/CYC1* plasmid, p*SMI1* bearing *C. albicans SMI1* gene or p*KNR4,* were grown overnight in liquid SD medium lacking uracil at 30 °C and concentrated to OD~600~ 8 ± 0. Serial dilutions of yeast cultures were spotted on YPD plates. Growth was scored after 2 days at 30 °C and 37 °C.

Deletion of *SMI1* renders *C. albicans* sensitive to cell wall targeting drugs {#s0055}
-------------------------------------------------------------------------------

We further investigated the role of Smi1 in maintaining cell wall integrity using a medically-relevant β-glucan synthase-targeting drug, the echinocandin caspofungin. The influence of Smi1 on the sensitivity to CFW was also retested in parallel. Deletions of both alleles of *SMI1* in the *C. albicans* BWP17 strain background (but bearing a functional *URA3* allele) led to a marked increase in sensitivity to caspofungin and CFW at 30 °C ([Fig. 2](#f0010){ref-type="fig"}). These phenotypes are consistent with those observed for the *S. cerevisiae knr4*Δ mutant and the proposed role of these proteins in stress signaling pathways (See Discussion). Re-integration of the *SMI1* open reading frame under the constitutive promoter *P~TDH3~* in the *smi1* Δ/Δ deletion mutant restored the wild-type phenotype ([Fig. 2](#f0010){ref-type="fig"}).Fig. 2Calcofluor White and caspofungin sensitivity of the *C. albicans smi*1 Δ/Δ mutant. The control strain BWP17 AHU, the mutant strain *smi1* Δ/Δ and the deletion mutant with *SMI1* gene re-integrated *smi1* Δ/Δ + *P~TDH3~-SMI1* were grown in liquid YPD medium at 30 °C to an OD~600~ of 1, and concentrated to OD~600~ 8 ± 0. Serial dilutions of yeast cultures were spotted on YPD plates in the absence or presence of 40 mg of CFW or 150 ng caspofungin ml^−1^. Growth was scored after 2 days at 30 °C.

Cell wall biophysics {#s0060}
====================

Cell wall strength/elasticity {#s0065}
-----------------------------

Atomic Force Microscopy (AFM) under liquid conditions can be used to investigate the nanomechnical properties of live wildtype and mutant cells ([@b0060], [@b0095], [@b0115], [@b0185]). Here we first measured the cell surface elasticity of three *C. albicans* strains: the control strain, BWP17 AHU, the homozygous deletion mutant *smi1* Δ/Δ and the strain over-expressing the *SMI1* from the *P~TDH3~* promoter in the BWP17 genetic background, *SMI1*-OE. Using the Atomic Force Microscope in the Force Volume mode, we collected between 1024 and 4160 force curves per cell on a minimum of 12 cells from 4 independent cultures for each strain. The elasticity of the cells was quantified from these curves by calculating the Young's Modulus (YM) as previously described ([@b0060]). The Young's Modulus represents the cell's stiffness: the higher the YM, the stiffer the cell. In the control strain, BWP17 AHU, the mean value ± SEM of the YM was 782 ± 70 kPa ([Fig. 3](#f0015){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}), significantly higher than that of the homozygous deletion mutant (mean ± SEM = 93 ± 33 kPa). The YM of the over-expression strain (mean ± SEM = 298 ± 62 kPa) lay between the control strain and the deletion mutant, suggesting either a gene dosage effect for *SMI1* expression or an effect of uncoupling the expression of this gene from the cell cycle. [Fig. 3](#f0015){ref-type="fig"}A shows maps of the recorded YM on square areas on the surfaces of three characteristic cells for each cell type, together with the corresponding topography maps. In this figure, the first line of maps (YM values of the control strain) is to compare with the third line (YM values of the homozygous deletion mutant) and the fifth line (YM values of the *SMI1* over-expressing strain). In addition, all the YM values recorded are represented for each cell individually on [Fig. 3](#f0015){ref-type="fig"}B, to allow visualization of cell-to-cell variability. Finally, [Fig. 3](#f0015){ref-type="fig"}C shows selected representative individual force curves for the three strains. These curves represent the force encountered while approaching the AFM tip vertically toward the cell surface. Before the tip touches the cell it does not encounter any resistance and the curve is simply horizontal. When the tip touches the cell (contact point), the curve starts to bend. Moving the tip further down results in indenting into the cell surface, where distinct resistance levels can be met. Hence, the slope of the second part of each curve represents the cell surface resistance against the ongoing progression of the tip: the steeper the slope, the harder the surface. These results therefore demonstrate that the deletion of both alleles of *SMI1* resulted in a reduction in cell wall stiffness by eight to ten folds, indicating that the cell wall integrity is compromised in this mutant.Fig. 3**A:** Elasticity maps recorded on independent cells of BWP17 AHU, *smi1* Δ/Δ and *SMI1*-OE strains. Maps of Young's Moduli (YM = 1/Elasticity) measured by Atomic Force Microscopy on independent cells of control strain BWP17 AHU, *smi1* Δ/Δ mutant and *SMI1*-OE strain. YM scales are shown (bright yellow: maximum at 500 kPa; dark red: minimum at 0.0 kPa). The corresponding topography map is presented below each elasticity map, also with scale (bright yellow: maximum at 500 nm; dark red: minimum at 0.0 nm). Analyzed areas cover squares of 1 × 1 to 2 × 2 µm^2^. **B:** Young's Moduli of *smi*1 Δ/Δ mutant and *SMI1*-OE *vs* control strain BWP17 AHU. Atomic Force Microscope was used to collect over 12,300 force curves for each strain on the control strain BWP17 AHU, the *smi1* Δ/Δ mutant and the *SMI1*-OE strain*.* The Young's Moduli quantified from these curves are presented here as a dot on the mean YM value, with SEM for each cell. The bar represents the mean of the YM values with each SEM. Statistical analysis was done using the One-way ANOVA test, ^\*\*\*\*^ = p value \< 0.0001. **C:** Representative Approach Force Curves of BWP17 AHU, *smi1* Δ/Δ and *SMI1*-OE. Forces measured by AFM in nN as a function of the indentation (tip position) in nm, for the three strains. BWP17 AHU: red curves, *smi1* Δ/Δ: black curves and *SMI1*-OE: blue. These force curves are obtained upon approaching the AFM tip towards the cell surface (horizontal part), touching the cell (contact point: where the curve starts to bend), further indenting into the cell surface and facing distinct resistance levels. The slope of the second part of each curve corresponds to the cell surface resistance against the tip progression.Table 2Summary of Atomic Force Microscopy measurements for BWP17 AHU, smi1 Δ/Δ, and SMI1-OE strains.Cell TypeYoung Modulus\
(kPa)^a^% of Adhesive\
Events^b^Mean Adhesion Force (pN)^c^Adhesion Energy\
*(=Area below the force curve*) (J)^d^BWP17 AHU782 (±70)46.1127 (±33)1.77 × 10^−17^*smi1* Δ/Δ93 (±33)19.470 (±16)0.26 × 10^−17^*SMI1*-OE298 (±62)62.9712 (±102)15.82 × 10^−17^[^1][^2][^3][^4]

Adhesion {#s0070}
--------

Another cell surface feature that can be easily and precisely measured by AFM is the ability to adhere to surfaces, using Single Molecule Force Spectroscopy ([@b0005], [@b0015], [@b0120], [@b0160], [@b0240]). Here, adhesion between the cell surface and the AFM bare tips, constituted of Si~3~N~4~, was measured by scanning areas of 1 µm^2^ on the top of individual yeast cells. We recorded force curves whose retraction values were used to generate adhesion maps where the intensity of each pixel corresponds to the force required to dissociate the AFM tip from the sample, *i*.*e*. the adhesion force, expressed in picoNewtons pN ([Fig. 4](#f0020){ref-type="fig"}). These data, represented as two-dimensional matrixes, show that the adhesion between the probe and the cell surface of the *smi1* Δ/Δ mutant was minimal compared to the control strain, while the cells of the *SMI1* over-expression strain displayed a marked increase in their surface adhesion. Cellular adhesion was also evaluated by three quantitative parameters: the mean adhesion force, the specific energy of each adhesion event observed, and the overall frequency of these adhesive events among all the recorded force curves. In order to quantify these values, we defined as an adhesive event any force curve showing an adhesion force above 50pN. Using this threshold level, we calculated the percentage of adhesive events for each cell type and measured the area situated below the retraction curves, which represent the adhesion energy of the event ([Table 2](#t0010){ref-type="table"}). These values indicated that adhesive events were encountered more frequently at the surface of the over-expressing strain *SMI1*-OE (63% of the recorded 21,500 force curves) than on the control strain (46% of over 13,500 force curves), and less frequently on the deletion mutant surface (19% of over 12,300 force curves). The mean adhesion force measured for the control strain was 127 ± 33 pN, calculated from 6200 adhesive force curves. This is to be compared with a mean ± SEM force of 70 ± 16 pN (barely above threshold) for 2300 force curves for the *smi1* Δ/Δ mutant. For the *SMI1*-OE-strain, adhesive events were more frequent (63%) and they were also much stronger, with forces measured up to 2176 pN with a mean value ± SEM of 712 ± 102 pN, calculated over 13,000 adhesive force curves. The specific energy of these adhesive events also differed; with adhesion energies for the over-expressing strain an order of magnitude stronger than that for the control strain, while they were approximately seven times lower on the surface of the deletion mutant. Hence, the homozygous deletion of *SMI1* gene abrogates almost entirely the ability of the mutant cell to adhere using the chemistry described here, while *SMI1* over-expression leads to a highly adhesive phenotype.Fig. 4Adhesion Maps recorded on the cellular surfaces of *smi* Δ/Δ mutant and SMI1-OE *vs* control strain. Adhesion force measurements were performed by Single Molecule Force Spectroscopy on *C. albicans* cells of the control strain BWP17 AHU, the *smi1* Δ/Δ mutant and the SMI1-OE strain over-expressing the *SMI1.* The adhesion maps presented have been recorded on three independent and representative *C. albicans* cells for each cell type. Each analyzed area covers 1 × 1 to 2 × 2 µm^2^. Adhesion scales are shown and read as follows: bright yellow = maximum adhesion force at 2 nN; dark red = minimum at 0.0 nN.

Cellular localization {#s0075}
=====================

GS-1, the homolog of Smi1 and Knr4 in the model filamentous fungus, *N. crassa*, localizes at the growing tip of hyphae as a sphere positioned at the "Spitzenkörper" ([@b0315]). The Spitzenkörper (or apical body) is a fungal structure specific to true hyphae, located at the hyphal tip. It is composed of the secretory vesicles that are required for continuous polarized growth ([@b0140], [@b0150]). GS-1-GFP and Knr4-GFP have been imaged at the tip of *N. crassa* hyphae (Riquelme et al., 2011; Sánchez-León et al., 2011; [@b0315]) and at the tip of elongated shmoos in *S. cerevisiae,* respectively (([@b0205]) and our unpublished data). To test whether the *C. albicans* homolog would be similarly positioned, a GFP-tag was integrated at the C-terminus of the Smi1 protein at its chromosomal locus and its cellular localization was visualized by confocal fluorescent microscopy in yeast and hyphal cells. This Smi1-GFP fusion protein is functional, as attested by its ability to complement the caspofungin and CFW hypersensitivity phenotypes of the *smi1* Δ/Δ mutant (not shown).

In yeast cells, Smi1-GFP appeared both as punctate patches in the cytoplasm and localized transiently to nascent buds ([Fig. 5](#f0025){ref-type="fig"}). This localization is similar to that reported for Knr4 in *S. cerevisiae* ([@b0055], [@b0200]). Punctate patches and a more diffuse cytoplasmic distribution were observed in *C. albicans* hyphae ([Fig. 5](#f0025){ref-type="fig"}), but, unlike in yeast, Smi1-GFP signal was consistently retained as a bright spot at the growing hyphal tip throughout the cell cycle, reminiscent of *N. crassa* GS-1 localization at the tip of growing hyphae ([@b0315]). Smi1-GFP was occasionally observed at hyphal septa as a dim signal, but this presence did not reflect specific stages of the cell cycle. Hence, Smi1 in *C. albicans* appears to associate with intracellular organelles and localizes to sites of new cell wall growth, a pattern which reflects those observed for homologs of Smi1 in *S. cerevisae* in yeast cells and the hyphae of *N. crassa*.Fig. 5Smi1-GFP localizes as patches concentrated to apical growth sites in yeasts and hyphae. Cells were grown on Ibidi µ-slides in YNB medium at 30 °C for 2 h (yeast) and 20% FBS, 2% glucose at 37 °C for 3 h (hyphae). Smi1-GFP localized transiently to emerging bud tips in yeasts (arrows) and to septa in hyphae (asterisks) but was maintained consistently at hyphal/branch tips (arrows). Punctate fluorescence patches were also observed throughout yeast and hyphal cells. Images are maximum projections of individual z-stacks.

Discussion {#s0080}
==========

Our results indicate that there is significant conservation of Knr4/Smi1 function in cell wall regulation between *S. cerevisiae* and *C. albicans* and demonstrate the role of Smi1 in tolerance to caspofungin, regulation of cell wall integrity and cell surface adhesion properties of this major human fungal pathogen. These features suggest that Smi1 might be relevant as a new drug target for combination therapies. Previous work by Nett and colleagues identified a role for Smi1 in the production of extracellular matrix during biofilm formation and hence the associated resistance to Fluconazole ([@b0235]). Their results indicated that these effects were linked to the cell wall integrity pathway but were in fact regulated by Smi1 independently of the CWI pathway, suggesting a control pathway for Smi1 distinct from that of the PKC pathway. Lafayette and colleagues dissected the mechanisms through which PKC regulates resistance to both azoles and echinocandins in the two yeast models, *C. albicans* and *S. cerevisiae* ([@b0175]). They showed that, in *C. albicans*, Pkc1 and calcineurin signaling pathways independently regulate antifungal resistance *via* a common unknown target, which they designed as "X" (see ([@b0175]), Fig. 9B thereof). Considering the knowledge accumulated on Knr4 in budding yeast together with the data obtained for *C. albicans* and presented here, we propose that Smi1 is a candidate for this previously unidentified "X", a common target of the Pkc1 and calcineurin signaling pathways. The marked reduction in cell-wall stiffness of the *smi1* Δ/Δ cell wall, as indicated by its Young's Modulus ([Fig. 3](#f0015){ref-type="fig"}, [Table 2](#t0010){ref-type="table"}), compared to the milder phenotype observed for the *S. cerevisiae knr4*Δ mutant ([@b0060]), suggests a more central role for Smi1 in the cell-wall integrity signaling network in *C. albicans* than that of Knr4 in the baker's yeast, which is in agreement with the hypothesis of LaFayette and colleagues ([@b0175]). The fact that the homozygous deletion mutant *smi1* Δ/Δ is so strongly affected, despite the presence in this strain of both functional alleles of *SMIB*, argues for a major role for the *SMI1* gene, at least in the conditions tested (30 °C, liquid rich medium, yeast form of *C. albicans* cells).

Our results show that homozygous deletion of *SMI1* leads to an increase in the sensitivity of *C. albicans* to both CFW and caspofungin at 30 °C. Caspofungin tolerance has been reported in *C. albicans* mutants that have elevated cell-wall chitin ([@b0250], [@b0255], [@b0325], [@b0345]), yet others report that elevated chitin can induce hypersensitivity to CFW (Elorza et al., 1983; Roncero and Durán, 1985). However, this dual sensitivity is consistent with the phenotype observed for the *S. cerevisiae knr4* Δ mutant ([@b0180], [@b0200]). Our cell wall stiffness measurements indicated that organization of the cell wall is significantly modified in the deletion mutant *smi1* Δ/Δ, consistent with a possible upstream role of Smi1 in cell-wall regulatory pathways. Early results obtained in bakers' yeast established a role for Knr4 in the transcriptional control of all *S. cerevisiae* chitin synthase genes ([@b0200]), so the role of Smi1 in *C. albicans* may also include control of expression levels of cell wall biosynthesis genes. The complex interplay of cellular signaling pathways controlling *C. albicans* susceptibility to echinocandins has been described by Munro and colleagues ([@b0320]), and it now seems possible that Smi1 is one piece of this puzzle. Indeed, a previous study investigating the effects of caspofungin on the cell walls of *S. cerevisiae* and *C. albicans* by AFM revealed that treatment with this echinocandin increased *C. albicans* cell wall stiffness and at the same time enhanced cell surface adhesion ([@b0115]). Although the high level of sensitivity to caspofungin of the *C. albicans smi1*Δ/Δ mutant meant that it was not possible to test this in this fungus, we speculate that Smi1 is a key player in the cellular response to caspofungin in *C. albicans*.

In *S. cerevisiae*, Knr4 is proposed to link the Ca^2+^/calcineurin/Crz1 signaling pathway with the Slt2/Mpk1 cell-wall integrity pathway. The cellular localization observed for Smi1-GFP in *C. albicans* yeasts and hyphae, as cytoplasmic patches and concentrated spots at the polarized growth sites, is consistent with the localizations reported for the MAP kinase Slt2 and calmodulin, the activator of calcineurin in *S. cerevisiae* ([@b0030], [@b0085]). Therefore, Smi1 in *C. albicans* could act as a similar link between these two signaling pathways, giving it a central role in cell-wall integrity signaling. In the model filamentous fungus, *N. crassa,* GS1, the homolog of Smi1, localizes at the Spitzenkörper within the hyphal tip ([@b0315]; Sánchez-León et al., 2011). This localization is conserved in another ascomycete filamentous fungus, *A. nidulans* (also called *Emericella nidulans*) (Schultzhaus et al., 2015). The results presented here indicate that Smi1 also localizes in or around the Spitzenkörper of *C. albicans* hyphae in a similar manner to that observed for GS-1 in *N. crassa*. Given the cell wall related phenotypes reported for GS-1 mutants of *N. crassa* ([@b0090], [@b0265], [@b0290]), the function of these proteins appears to be not only conserved between *C. albicans* and *S. cerevisiae*, but also to some extent in filamentous fungi.

Finally, the role of Smi1 in the control of cell wall synthesis, cellular adhesion and drug resistance is relevant to the search for new antifungal targets. An advantage of Smi1 as a drug target over Hsp90, calcineurin, Pkc1 or other MAP kinases is the specificity of the Knr4/Smi1 superfamily of proteins to the Fungal Kingdom as it is absent from host cells ([@b0215]). In addition, since this protein family is conserved among fungi, including other fungal pathogens of mammals (*C. glabrata* and *Aspergillus species* notably) and also plants (ex: *Magnaporthe grisea*), developing drugs that target Smi1 might lead to broader antifungal applications in domains such as agriculture.
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[^1]: ^a^Mean values with standard deviation of Young's Moduli calculated from force curves obtained as described above (3.1).

[^2]: ^b^Percentage of adhesive events measured by AFM, calculated from at least 12,000 force curves for each cell type, with a threshold level for the definition of an adhesive event as 50pN on the retraction curve.

[^3]: ^c^Mean values of Adhesion forces for each cell type, calculated from adhesive force curves obtained as described above.

[^4]: ^d^Mean values of the Adhesion Energy for each strain, calculated from the area below the force curves presenting an adhesion event.
